Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2040)	12/6/2007 11:24:37 AM
From: Jibacoa	Respond to of 3722

SIGA Opened with an UG but still wasn't able to test the resistance at the $4 level.<g> bigcharts.marketwatch.com It said that although the final results of its ST-246 for smallpox weren't available, preliminary results indicated that the drug is safe and well-tolerated at all tested doses when administered orally for 21 days to healthy human volunteers. The blood levels were dose-dependent & the levels obtained were the same as those shown to protect monkeys.The drug's half-life was sufficient to support once-a-day dosing. They continue to consider that ST-246 will be a potent, safe & reliable drug against smallpox. The stock isn't off as yet from its longer term DT coming from the April H at 5.96 bigcharts.marketwatch.com Bernard